Valor20202021202220232024TTMFluxo de caixa de investimento-7.26 M11.78 M9.7 M10.58 M8.03 M11.32 MFluxo de caixa de financiamento61.4 M7.5 M8.02 M8.84 M9.53 M—Fluxo de caixa livre-30.91 M-36.5 M-22.86 M-18.02 M-19.83 M-21.69 M
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.